Company news
Envoy Medical, Inc. (NASDAQ:COCH) news
Envoy Medical, Inc. news releases on 6ix. Latest, Aug 20, 2025: Envoy Medical Secures Three New Patents, Strengthening Leadership in Fully Implantable Hearing…
Press releases — page 2
Envoy Medical Secures Three New Patents, Strengthening Leadership in Fully Implantable Hearing Technology
August 20, 2025
Envoy Medical Reports on Second Quarter 2025 Results
July 31, 2025
Envoy Medical Expands Patent Portfolio with New Issuances in the United States
July 8, 2025
Envoy Medical Expands Global Patent Portfolio with New Issuances in Australia
July 1, 2025
New CPT Codes for Totally Implantable Active Middle Ear Hearing Implants Go into Effect July 1, Unlocking New Opportunities for Envoy Medical
June 26, 2025
Envoy Medical to Present at the Life Sciences Virtual Investor Forum June 12th
June 11, 2025
Envoy Medical's Pivotal Clinical Trial for Fully Implanted Acclaim(R) Cochlear Implant Remains On Track After First Month Follow-Up
June 10, 2025
Envoy Medical Achieves Clinical Trial Milestone and is Optimistic About Expansion into Final Stage of Trial
May 13, 2025
Envoy Medical Reports on First Quarter 2025 Results
May 1, 2025
Envoy Medical Reports Fourth Quarter and Full Year 2024 Financial Results
March 31, 2025
Hearing Device Coverage Clarification Act Reintroduced in House and Senate
March 17, 2025
Envoy Medical Secures $10 Million in Funding to Advance Pivotal Clinical Trial of Breakthrough Hearing Device
March 12, 2025
Envoy Medical to Participate in the 37th Annual ROTH Conference
March 10, 2025
First Two Participants Successfully Enrolled In Pivotal Clinical Study For Breakthrough Fully Implanted Cochlear Implant
February 24, 2025
Envoy Medical Secures Additional Patent Protection for Its Growing Patent Portfolio
February 13, 2025
Envoy Medical Names Seven Investigational Sites for Participation in Its Pivotal Clinical Study
December 18, 2024
Envoy Medical Receives Additional Patent Protection for its Innovative Approach to Hearing Loss
December 15, 2024
Envoy Medical Reports Third Quarter 2024 Results and Other Exciting Events
November 13, 2024
Envoy Medical Receives Another European Patent for its Modular Cochlear Implant System
November 7, 2024
Envoy Medical Receives FDA Approval To Initiate Pivotal Clinical Study for Breakthrough Hearing Device
October 31, 2024
Envoy Medical Awarded Patent for Recharge System used with Implantable Battery
September 15, 2024
Envoy Medical Secures Lending Facility of $10M
August 27, 2024
Envoy Medical Reports Second Quarter 2024 Results and Provides Business Update
August 11, 2024
Envoy Medical Announces Inclusion in the Russell Microcap Index
June 30, 2024
Envoy Medical Announces Addition of Medical Device Manufacturing Experience to its Board of Directors to Prepare for Scaling
June 10, 2024
Envoy Medical Announces Inclusion in the MSCI USA Micro Cap Index
June 5, 2024
Envoy Medical Reports First Quarter 2024 Results
May 14, 2024
Envoy Medical Reports Fourth Quarter and Full Year 2023 Financial Results
April 1, 2024
Envoy Medical Secures Up To $10 Million Term Debt Financing to Advance Upcoming Clinical Trial
March 3, 2024
Envoy Medical Announces Three Additional Patents for Implantable Cochlear Systems
January 21, 2024
Envoy Medical Provides Third Quarter 2023 Financial Results and Business Update
November 19, 2023
Envoy Medical Announces Publication of Additional Patent for Implantable Cochlear Systems
November 9, 2023
Envoy Medical Announces Settlement Contract
October 9, 2023
Envoy Medical Announces Participation in the LD Micro Main Event XVI
October 2, 2023
Envoy Medical Announces Shareholder Approval on Proposed Merger with Anzu Special Acquisition Corp I
September 27, 2023
Envoy Medical Announces Proposed Board Slate of Experienced Medical Device and Financial Leaders
September 18, 2023
Envoy Medical Appoints David R. Wells as Chief Financial Officer
August 23, 2023